The relationship between effluent potassium due to cellular release, free water transport and CA125 in peritoneal dialysis patients

NDT Plus

Volumn 1, Issue SUPPL. 4, 2008, Pages

  Coester, Annemieke M ^a   Zweers, Machteld M ^a   De Waart, Dirk R ^a   Krediet, Raymond T ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CA 125 ANTIGEN; CREATININE; HYPERTONIC SOLUTION; POTASSIUM;

ADULT; AGED; CELL SHAPE; CONFERENCE PAPER; CONTROLLED STUDY; DIFFUSION; EFFLUENT; FLUID TRANSPORT; HUMAN; MAJOR CLINICAL STUDY; MESOTHELIUM CELL; PERITONEAL DIALYSIS; POTASSIUM TRANSPORT; PRIORITY JOURNAL; THERMODYNAMICS; TREATMENT DURATION; WATER TRANSPORT;

EID: 57349155637     PISSN: 17530784     EISSN: 17530792     Source Type: Journal    
DOI: 10.1093/ndtplus/sfn123     Document Type: Conference Paper

References (29)

1. Coester AM, Struijk DG, Smit W et al. The cellular contribution to effluent potassium and its relation with free water transport during peritoneal dialysis. Nephrol Dial Transplant 2007; 22: 3593-3600
2. Goffin E, Combet S, Jamar F et al. Expression of aquaporin-1 in a long-term peritoneal dialysis patient with impaired transcellular water transport. Am J Kidney Dis 1999; 33: 383-388
3. Koomen GC, Betjes MG, Zemel D et al. Dialysate cancer antigen (CA) 125 is a reflection of peritoneal cell mass in CAPD patients. Perit Dial Int 1994; 14: 132-136
4. Visser CE, Brouwer-Steenbergen JJ, Betjes MG et al. Cancer antigen 125: a mesothelial bulk marker for mesothelial mass in stable peritoneal dialysis. Nephrol Dial Transplant 1995; 10: 64-69
5. Zeilemaker AM, Verbrugh HA, Hoynck van Papendrecht AA et al. CA 125 secretion by peritoneal mesothelial cells. J Clin Pathol 1994; 47: 263-265
6. Krediet RT. Dialysate cancer antigen 125 concentration as marker of peritoneal membrane status in patients treated with chronic peritoneal dialysis. Perit Dial Int 2001; 21: 560-567
7. Sanusi AA, Zweers MM, Weening JJ et al. Expression of cancer antigen 125 by peritoneal mesothelial cells is not influenced by duration of peritoneal dialysis. Perit Dial Int 2001; 21: 495-500
8. Pannekeet MM, Imholz AL, Struijk DG et al. The Standard Peritoneal Permeability Analysis: a tool for the assessment of peritoneal permeability characteristics in CAPD patients. Kidney Int 1995; 48: 866-875
9. Renck H, Ljungstrom HG, Hedin H et al. Prevention of dextran induced anaphylactic reaction by hapten inhibition. Acta Chir Scand 1983; 149: 355-360
10. Ho-Dac-Pannekeet MM, Hiralall JK, Struijk DG et al. Longitudinal follow-up of CA125 in peritoneal effluent. Kidney Int 1997; 51: 888-893
11. Pannekeet MM, Koomen GC, Struijk DG et al. Dialysate CA125 in stable CAPD patients. Clin Nephrol 1995; 44: 248-254
12. Koomen GC, Krediet RT, Leegwater AC et al. A fast reliable method for the measurement of intraperitoneal dextran 70, used to calculate lymphatic absorption. Adv Perit Dial 1991; 7: 10-14
13. Waniewski J, Werynski A, Heimburger A et al. Simple models for description of small solute transport in peritoneal dialysis. Blood Purif 1991; 9: 129-141
14. Waniewski J, Heimburger A, Werynski A et al. Aqueous solute concentrations and evaluation of mass transfer area coefficients in peritoneal dialysis. Nephrol Dial Transplant 1992; 7: 50-56
15. Smit W, Struijk DG, Ho-Dac-Pannekeet MM et al. Quantification of free water transport in peritoneal dialysis. Kidney Int 2004; 66: 849-854
16. Zweers MM, Imholz AL, Struijk DG et al. Correction of sodium sieving for diffusion from the circulation. Adv Perit Dial 1999; 15: 65-72
17. Mujais S, Nolph K, Gokal R et al. International Society for Peritoneal Dialysis Ad Hoc Committee on Ultrafiltration Management in Peritoneal Dialysis. Evaluation and management of ultrafiltration problems in peritoneal dialysis. Perit Dial Int 2000; 20(Suppl 4): S5-S21
18. Zweers MM, Splint LJ, Krediet RT et al. Ultrastructure of basement membranes of peritoneal capillaries in a chronic peritoneal infusion model in the rat. Nephrol Dial Transplant 2001; 13: 651-654
19. Davies SJ, Philips L, Naish PF et al. Peritoneal glucose exposure and changes in membrane solute transport with time on peritoneal dialysis. J Am Soc Nephrol 2001; 12: 1046-1051
20. Selgas R, Fernandez-Reyes MJ, Bajo MA et al. Functional longevity of the human peritoneum: how long is continuous peritoneal dialysis possible? Am J Kidney Dis 1994; 23: 64-73
21. Parikova A, Smit W, Struijk DG et al. The contribution of free water transport and small pore transport to the total fluid removal in peritoneal dialysis. Kidney Int 2005; 68: 1849-1856
22. Pecoits-Filho R, Araujo MR, Lindholm B et al. Plasma and dialysate IL-6 and VEGF concentrations are associated with high peritoneal solute transport rate. Nephrol Dial Transplant 2002; 17: 1480-1486
23. Ha H, Cha MK, Choi HN et al. Effects of peritoneal dialysis solutions on the secretion of growth factors and extracellular matrix proteins by human peritoneal mesothelial cells. Perit Dial Int 2002; 22: 171-177
24. van Esch S, Zweers MM, Jansen MA et al. Determinants of peritoneal solute transport rates in newly started nondiabetic peritoneal dialysis patients. Perit Dial Int 2004; 24: 554-561
25. Rodrigues A, Martins M, Santos MJ et al. Evaluation of effluent markers cancer antigen 125, vascular endothelial growth factor, and interleukin-6: relationship with peritoneal transport. Adv Perit Dial 2004; 20: 8-12
26. Mateijsen MA, Van Der Wal AC, Hendriks PM et al. Vascular and interstitial changes in the peritoneum of CAPD patients with peritoneal sclerosis. Perit Dial Int 1997; 19: 517-525
27. Jiminez C, Diaz C, Selgas R et al. Peritoneal kinetics of cancer antigen 125 in peritoneal dialysis patients: the relationship with peritoneal outcome. Adv Perit Dial 1999; 15: 36-39
28. Breborowicz A, Polubinska A, Oreopoulos DG. Changes in volume of peritoneal mesothelial cells exposed to osmotic stress. Perit Dial Int 1999; 19: 119-123
29. Flessner M, Henegar J, Bigler S et al. Is the peritoneum a significant transport barrier in peritoneal dialysis? Perit Dial Int 2003; 23: 542-549